An expert answered CURE® readers’ questions on several aspects of a prostate cancer journey, including treatment options and sexual function. A prostate cancer journey can involve plenty of questions.

Prostate cancer treatments lead to higher long-term complication rates, emphasizing the need for informed decision-making regarding treatment options and side effects. Prostatectomy patients ...

Men with advanced prostate cancer undergoing local therapies such as radiation therapy or radical prostatectomy experience significantly more gastrointestinal and sexual issues, along with problems ...

NEW YORK (Reuters Health) - An expensive prostate cancer radiation treatment known as proton beam therapy has just as many side effects as a more common and cheaper radiation method, according to a ...

For patients with intermediate-risk, localized prostate cancer, radiation therapy delivered in five sessions reduced patient-reported side effects compared to longer courses of radiation, according to ...

Defense Secretary Lloyd Austin's medical issues last December put the spotlight on fighting prostate cancer while reducing the risk of side effects and complications. A trial here on a less invasive ...

Men undergoing radiation therapy for prostate cancer who experience side effects early in treatment may face a higher risk of developing more serious long-term urinary and bowel health issues, ...

The long-term outlook for men diagnosed with prostate cancer continues to improve. About 98% are living for 10 years or more after diagnosis, and the survival rate at 15 years now exceeds 95%. These ...

Join Tom and Mike as they share an important update on Tom's prostate cancer journey. In this video, they discuss Tom's ...

Ashwagandha may cause side effects like nausea, drowsiness, and headache. It may not be safe for people who are pregnant or have thyroid or prostate problems.

Francis Medical, Inc., a privately-held medical device company developing the breakthrough Vanquish(R) Water Vapor Ablation System for the management of prostate cancer, today announced that the U.S.